Blood Pressure After PREeclampsia/HELLP by SELF Monitoring Study
NCT03228082 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2020-10-06
Summary
RATIONALE:
Women with a previous history of preeclampsia (PE)/HELLP have a twofold higher risk of cardiovascular disease (CVD) and a fourfold increased risk to develop hypertension at a relative young age. In the latest 2016 ESC guidelines 'CVD prevention', previous PE has been acknowledged as a serious CVD risk factor in women. In clinical practice, however, these women are still underappreciated for their CVD risk. It has not been established yet how adequate lifelong prevention in these potentially high risk women can optimally be achieved from their childbearing years onwards.
OBJECTIVE:
To evaluate feasibility, usability, acceptance and potential obstacles of blood pressure (BP) home monitoring in high-risk women, aged 40-60 years, after a previous PE in pregnancy. In addition to evaluate the effectiveness of BP home monitoring on the occurrence of hypertension, the efficacy of BP treatment, quality of life (QOL), health-related symptoms, work ability and life-style behaviour.
STUDY DESIGN:
Randomized, open label feasibility study to compare eHealth guided self management of BP monitoring and lifestyle advice with 'usual care'.
STUDY POPULATION:
Approximately 200 women, aged ≥ 40 and ≤ 60 years, with a previous PE in pregnancy will be invited to participate (both early and late PE). Patients will be recruited from the departments of obstetrics/gynaecology in 6 centres in the Euregio Rhein-Waal and from the department of cardiology Radboudumc.
INTERVENTION:
eHealth guided measurements of BP at regular intervals and recurrent lifestyle advice (intervention-group) will be compared with "usual care".
PRIMARY OUTCOME:
Feasibility, usability, acceptance and potential obstacles of BP home monitoring in high-risk women after a previous PE in pregnancy at 1 year of follow-up.
Conditions
- Preeclampsia
- Cardiovascular Risk Factor
- Cardiovascular Diseases
- Hypertension
Interventions
- DEVICE
-
Home Blood Pressure Monitoring (HBPM)
Home blood pressure monitoring using the Withings Wireless BP monitor. Patients will be asked to measure their blood pressure twice daily for 7 consecutive days. This will be repeated for every month for 1 year.
Sponsors & Collaborators
-
Interreg
collaborator OTHER -
Radboud University Medical Center
lead OTHER
Principal Investigators
-
A.H.E.M. Maas, Prof.dr. · Radboudumc, department Cardiology
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DEVICE_FEASIBILITY
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Max Age
- 60 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-07-13
- Primary Completion
- 2019-12-30
- Completion
- 2019-12-30
Countries
- Germany
- Netherlands
Study Locations
More Related Trials
-
Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia
NCT02147626 ·Status: COMPLETED ·Phase: NA
-
Ambulatory Blood Pressure Monitoring in Post-Partum Pre-Eclamptic Patients
NCT02943122 ·Status: COMPLETED
-
Vascular Biomarkers Predictive of the Progression From Hypertensive Disorders in Pregnancy to Preeclampsia in Pregnant Women
NCT04520048 ·Status: RECRUITING ·Phase: NA
-
Blood Pressure Monitoring in High Risk Pregnancy to Improve the Detection and Monitoring of Hypertension
NCT03334149 ·Status: COMPLETED ·Phase: NA
-
Innovation in Postpartum Care for Women With Hypertensive Disorders of Pregnancy
NCT03613714 ·Status: COMPLETED ·Phase: NA
-
Identifying Biomarkers for Endothelial Dysfunction in Women With Preeclampsia
NCT07084727 ·Status: RECRUITING ·Phase: NA
-
Cardiovascular Protection After Preeclampsia With Enalapril
NCT07222852 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy
NCT06523569 ·Status: RECRUITING ·Phase: NA
-
LimPrOn: Limburg Pre-eclampsia Investigation
NCT03509272 ·Status: RECRUITING ·Phase: NA
-
Premom: Pregnancy Remote Monitoring
NCT03246737 ·Status: COMPLETED
-
Heart Failure and Related Risk-factors After Preeclampsia
NCT02347540 ·Status: UNKNOWN
-
Understanding Blood Pressure Changes After Birth
NCT05137808 ·Status: UNKNOWN
-
Self-management of Postnatal Anti-hypertensive Treatment: a Trial Development Pilot Study
NCT02333240 ·Status: COMPLETED ·Phase: NA
-
Left Ventricular and Endothelial Function in Preeclampsia
NCT00201500 ·Status: COMPLETED
-
Post-Pregnancy Cardio Trial
NCT03313063 ·Status: COMPLETED
-
Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia
NCT06220721 ·Status: RECRUITING ·Phase: NA
-
Predicting Late-onset Preeclampsia at 10-14 Weeks of Pregnancy
NCT04075708 ·Status: COMPLETED
-
The PreEclampsia Postpartum Prevention Trial
NCT07199283 ·Status: RECRUITING ·Phase: NA
-
Accuracy Assessment of an Automatic Blood Pressure Measurement Device in Pregnant Women
NCT02319174 ·Status: COMPLETED ·Phase: NA
-
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
NCT05826925 ·Status: RECRUITING ·Phase: NA
-
Cardiovascular Risk in Infants Exposed to Pre-eclampsia in Utero
NCT05091827 ·Status: UNKNOWN
-
Hypertensive Pregnant Women Monitored by Teletransmitted Self-measurements of Blood Pressure
NCT03648645 ·Status: UNKNOWN ·Phase: NA
-
Balance of Angiotensin II Receptors in Vessel Function After Preeclampsia
NCT06157580 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Preeclampsia: A Marker for Future Cardiovascular Risk in Women
NCT01519297 ·Status: SUSPENDED ·Phase: NA
-
Goal-Directed Therapy in Pregnant Women at High Risk of Developing Preeclampsia
NCT01351428 ·Status: COMPLETED ·Phase: NA